Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis

ClinicalTrials.gov ID: NCT01240915

Public ClinicalTrials.gov record NCT01240915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 12:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study To Investigate The Safety And Efficacy Of Multistem (Pf-05285401) In Subjects With Moderate To Severe Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

MultiStem(r) is a new biological product, manufactured from human stem cells obtained from adult bone marrow or other nonembryonic tissue sources. Factors expressed by MultiStem cells are believed to reduce inflammation and regulate immune system function, protect damaged or injured cells and tissue, promote formation of new blood vessels, and augment tissue repair and healing. MultiStem cell treatment resulted in significant efficacy in a mouse model of Graft versus Host Disease with almost complete reversal of gastrointestinal pathology (similar to pathology that would be expected in Ulcerative Colitis). These data, together with safety data generated in 2 other clinical trials, suggest that MultiStem has the potential to be a new treatment option for patients with ulcerative colitis. This is the first study of MultiStem in this patient population and will cautiously explore the safety/toleration and potential benefit of this new treatment in patients with moderate to severe disease.

Study identification

NCT ID
NCT01240915
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
105 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2011 (Type not available)
Primary completion
Nov 2014 (Actual)
Completion
Nov 2014 (Actual)
Last update posted
Feb 23, 2016

2011 – 2014

United States locations

U.S. sites
37
U.S. states
15
U.S. cities
27
Facility City State ZIP Site status
University of California San Francisco San Francisco California 94115 —
USCF Endoscopy Unit at Mount Zion San Francisco California 94115 —
Clinical Research of the Rockies Lafayette Colorado 80026 —
Rocky Mountain Gastroenterology Associates, LLC Lakewood Colorado 80215 —
Arapahoe Gastroenterology, PC Littleton Colorado 80120 —
Metropolitan Gastroenterology Group, PC Washington D.C. District of Columbia 20006 —
Gastroenterology Consultants of Clearwater Clearwater Florida 33756 —
West Coast Endoscopy Center Clearwater Florida 33756 —
Clinical Research of West Florida, Inc. Clearwater Florida 33765 —
Borland-Groover Clinic Jacksonville Florida 32256 —
Jacksonville Center for Endoscopy Jacksonville Florida 32256 —
Miami Research Associates South Miami Florida 33143 —
University of Chicago Medical Center Chicago Illinois 60637 —
Cotton-O'Neil Clinical Research Center, Digestive Health Topeka Kansas 66606 —
University of Louisville Healthcare Outpatient Center Louisville Kentucky 40202 —
University of Louisville Hospital Louisville Kentucky 40202 —
Metropolitan Gastroenterology Group, PC - Chevy Chase Clinical Research Chevy Chase Maryland 20815 —
Endoscopic Microsurgery Associates, PA Towson Maryland 21204 —
Clinical Research Institute of Michigan, LLC Chesterfield Michigan 48047 —
Center for Digestive Health Troy Michigan 48098 —
Utica Surgery Center Utica Michigan 48317 —
Surgery Center of Columbia Columbia Missouri 65201 —
Center for Digestive and Liver Diseases, Inc. Mexico Missouri 65265 —
Present, Chapman, Steinlauf and Marion New York New York 10028 —
Mount Sinai School of Medicine New York New York 10029 —
Asher Kornbluth, MD PC New York New York 10128 —
Charlotte Gastroenterology and Hepatology, PLLC Charlotte North Carolina 28207 —
Wake Internal Medicine Consultants, Inc. Raleigh North Carolina 27612 —
Wake Research Associates Raleigh North Carolina 27612 —
Wake Forest University University Baptist Medical Center - Internal Medicine Winston-Salem North Carolina 27157 —
Gastro One Germantown Tennessee 38138 —
Vanderbilt University Medical Center Nashville Tennessee 37232-1375 —
Digestive and Liver Disease Specialists Norfolk Virginia 23502 —
Sentara Leigh Hospital Norfolk Virginia 23502 —
Sentara Norfolk General Hospital Norfolk Virginia 23507 —
McGuire DVAMC Richmond Virginia 23249 —
University of Washington Medical Center Seattle Washington 98195 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01240915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 23, 2016 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01240915 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →